Ruth Board - Concepedia

Author

Ruth Board

University of Manchester ORCID

Also Known As

Board, R, Board, Ruth, Mazhar Ajaz, R BOARD, R Board, R E Board, R. Board, R. E. Board, R.E. BOARD, R.E. Board

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

University of Manchester Cancer Research UK Manchester Institute Lancashire Teaching Hospitals NHS Foundation Trust The Christie NHS Foundation Trust Royal Preston Hospital

About

Ruth Board is an author at University of Manchester specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.3K
2	Biochemistry	2	2	84
3	Engineering	1	1	27
4	Natural Sciences	1	1	57
5	Public Health	1	1	599

Ruth Board

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey, The Lancet Oncology Primary Tumour SubtypeEpidemiologyCancer EpidemiologyCovid-19 PrevalenceMedicine	2020	599
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma Karla A. Lee, Andrew Maltez Thomas, Laura A. Bolte, Nature Medicine	2022	397
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker Leila Khoja, Alison Backen, Robert Szczepaniak‐Sloane, British Journal of Cancer	2011	252
Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy Jianmei Hou, Alastair Greystoke, Lee Lancashire, American Journal Of Pathology Prognostic BiomarkersMedicineCirculating Tumor CellsPathologyBronchial Neoplasm	2009	237
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer Ruth Board, Andrew Wardley, J. Michael Dixon, Breast Cancer Research and Treatment Breast OncologyOncologyCancer DetectionMedicinePathology	2010	199
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study Pippa Corrie, Andrea Marshall, Janet Dunn, The Lancet Oncology	2014	109
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, Nature Medicine	2024	108
Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer Ruth Board, Victoria Williams, Lucy Knight, Annals of the New York Academy of Sciences	2008	103
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study Ruth Board, Gillian Ellison, Maria Orr, British Journal of Cancer	2009	100
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma Laura A. Bolte, Karla A. Lee, Johannes R. Björk, JAMA Oncology	2023	83

Page 1